Blanco J, Garcia Alonso A, Garcia A, Hermida-Nogueira L, Castro A
Periodontol 2000. 2024; 97(1):74-94.
PMID: 38923566
PMC: 11808445.
DOI: 10.1111/prd.12570.
Monzani D, Liberale C, Segato E, De Cecco F, Arietti V, Palma S
Medicina (Kaunas). 2023; 59(11).
PMID: 38004026
PMC: 10673203.
DOI: 10.3390/medicina59111977.
Zhao R, Su Z, Komissarov A, Liu S, Yi G, Idell S
Front Immunol. 2021; 12:691249.
PMID: 34025688
PMC: 8138429.
DOI: 10.3389/fimmu.2021.691249.
Memtsas V, Arachchillage D, Gorog D
Int J Mol Sci. 2021; 22(3).
PMID: 33540604
PMC: 7867291.
DOI: 10.3390/ijms22031472.
Duval C, Profumo A, Aprile A, Salis A, Millo E, Damonte G
J Thromb Haemost. 2020; 18(4):802-814.
PMID: 31889430
PMC: 7186824.
DOI: 10.1111/jth.14725.
Fibrinogen alpha amyloidosis: insights from proteomics.
Chapman J, Dogan A
Expert Rev Proteomics. 2019; 16(9):783-793.
PMID: 31443619
PMC: 6788741.
DOI: 10.1080/14789450.2019.1659137.
Fibrin Formation, Structure and Properties.
Weisel J, Litvinov R
Subcell Biochem. 2017; 82:405-456.
PMID: 28101869
PMC: 5536120.
DOI: 10.1007/978-3-319-49674-0_13.
Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease.
Lock-Johansson S, Vestbo J, Sorensen G
Respir Res. 2014; 15:147.
PMID: 25425298
PMC: 4256818.
DOI: 10.1186/s12931-014-0147-5.
Fibrinogen Philadelphia. A hereditary hypodysfibrinogenemia characterized by fibrinogen hypercatabolism.
Martinez J, HOLBURN R, Shapiro S, ERSLEV A
J Clin Invest. 1974; 53(2):600-11.
PMID: 11344575
PMC: 301504.
DOI: 10.1172/JCI107595.
Studies of the metabolism and distribution of fibrinogen in patients with hemophilia A.
Takeda Y, Chen A
J Clin Invest. 1967; 46(12):1979-85.
PMID: 6074002
PMC: 292950.
DOI: 10.1172/JCI105687.
Human prothrombin metabolism in normal man and in hypocoagulable subjects.
Shapiro S, Martinez J
J Clin Invest. 1969; 48(7):1292-8.
PMID: 5794251
PMC: 322352.
DOI: 10.1172/JCI106095.
Pharmacological enhancement of fibrinolytic activity and 125I-fibrinogen survival.
Hickman J
J Clin Pathol. 1970; 23(9):797-800.
PMID: 5504373
PMC: 476900.
DOI: 10.1136/jcp.23.9.797.
Isotopic studies of therapeutic anticoagulation with a coagulating enzyme.
Bell W, REGOECZI E
J Clin Invest. 1970; 49(10):1872-9.
PMID: 5456799
PMC: 322677.
DOI: 10.1172/JCI106406.
Direct measurement of the rates of synthesis of plasma proteins in control subjects and patients with gastrointestinal protein loss.
WOCHNER R, Weissman S, Waldmann T, Houston D, BERLIN N
J Clin Invest. 1968; 47(5):971-982.
PMID: 5239039
PMC: 297250.
DOI: 10.1172/JCI105812.
Hyperacute rejection of renal homografts: with particular reference to coaglation changes, humoral antibodies, and formed blood elements.
BOEHMIG H, Giles G, Amemiya H, Wilson C, Coburg A, Genton E
Transplant Proc. 1971; 3(2):1105-17.
PMID: 4944050
PMC: 2840626.
Plasminogen- 125 I responses in dogs to a single injection of urokinase and typhoid vaccine and to vascular injury.
Takeda Y
J Clin Invest. 1972; 51(6):1363-77.
PMID: 4623459
PMC: 292273.
DOI: 10.1172/JCI106932.
Measurement of fibrinopeptide A in human blood.
Nossel H, Yudelman I, Canfield R, Butler Jr V, Spanondis K, Wilner G
J Clin Invest. 1974; 54(1):43-53.
PMID: 4600045
PMC: 301523.
DOI: 10.1172/JCI107749.
The significance of variations in immunoreactive and clottable fibrinogen in health and following thrombosis.
Wolf P, Farrell G, Walton K
J Clin Pathol. 1972; 25(1):36-44.
PMID: 4259368
PMC: 477218.
DOI: 10.1136/jcp.25.1.36.
Plasma fibrinogen levels in normal and sick cows.
McSherry B, Horney F, DeGroot J
Can J Comp Med. 1970; 34(3):191-7.
PMID: 4248439
PMC: 1319491.
Antihemophilic factor antigen. Localization in endothelial cells by immunofluorescent microscopy.
HOYER L, De los Santos R, Hoyer J
J Clin Invest. 1973; 52(11):2737-44.
PMID: 4201264
PMC: 302541.
DOI: 10.1172/JCI107469.
